GTS Securities’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7,888
| Closed | -$709K | – | 1310 |
|
|
2024
Q3 | $709K | Sell |
7,888
-1,253
| -14% | -$113K | ﹤0.01% | 850 |
|
|
2024
Q2 | $736K | Sell |
9,141
-9,354
| -51% | -$753K | ﹤0.01% | 777 |
|
|
2024
Q1 | $1.48M | Buy |
18,495
+207
| +1% | +$16.5K | ﹤0.01% | 426 |
|
|
2023
Q4 | $1.46M | Buy |
18,288
+10,738
| +142% | +$855K | ﹤0.01% | 483 |
|
|
2023
Q3 | $528K | Buy |
7,550
+877
| +13% | +$61.3K | ﹤0.01% | 755 |
|
|
2023
Q2 | $480K | Buy |
+6,673
| New | +$480K | 0.02% | 677 |
|